Goodman Vicki L
SEC CIK 1901477 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS, INC. | EVP, CMO, Prod Dev, Med Aff | 307.7K | — | — | 4 | 2022-01-04 | 2023-04-03 |
Most active insiders at EXEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Aftab Dana | EVP, Research, Development | — | $7.70M |
| 2 | Haley Patrick J. | EVP, Commercial | — | $7.60M |
| 3 | Smith Julie | Dir | — | $4.69M |
| 4 | WYSZOMIERSKI JACK L | Dir | — | $4.58M |
| 5 | Senner Christopher J. | EVP, CFO | — | $4.56M |
| 6 | PAPADOPOULOS STELIOS | Dir | — | $4.36M |
| 7 | POSTE GEORGE | Dir | — | $2.74M |
| 8 | Beckerle Mary C | Dir | — | $1.93M |
| 9 | Oliver Bob | Dir | — | $1.33M |
| 10 | Caligan Partners LP | Dir, See Remarks | $1.19M | — |
Goodman Vicki L made no open-market trades at EXEL in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-05 | 2023-04-03 | EXEL | EXELIXIS, INC. | Goodman Vicki L | EVP, CMO, Prod Dev, Med Aff | A - Grant | $0.00 | +82.6K | 307.7K | +37% | $0 | |
| 2023-02-17 | 2023-02-15 | EXEL | EXELIXIS, INC. | Goodman Vicki L | EVP, CMO, Prod Dev, Med Aff | F - Tax | $18.08 | -17.3K | 225.1K | -7% | -$312.8K | |
| 2022-01-06 | 2022-01-04 | EXEL | EXELIXIS, INC. | Goodman Vicki L | EVP, CMO, Prod Dev, Med Aff | A - Grant | $0.00 | +250.0K | 250.0K | New | $0 | |
| 2022-01-06 | 2022-01-04 | EXEL | EXELIXIS, INC. | Goodman Vicki L | EVP, CMO, Prod Dev, Med Aff | F - Tax | $19.18 | -7,613 | 242.4K | -3% | -$146.0K |
Purchase Sale Sale after option exercise All abbreviations